Wide-field OCT imaging market seen reaching $1.8 billion by 2030

The wide-field optical coherence tomography imaging market is projected to grow from $1.14 billion in 2025 to $1.24 billion in 2026, then reach $1.8 billion by 2030, according to new research from The Business Research Company. The report points to rising retinal disease screening, AI-enabled diagnostics and expanding teleophthalmology as key drivers, with North America leading now and Asia-Pacific expected to grow fastest.

Why it matters: - Wide-field OCT imaging is becoming a more important tool in eye care because it helps clinicians detect, diagnose and monitor retinal disease earlier. - The market’s projected expansion signals growing demand for advanced ophthalmic imaging as diabetes, vision disorders and preventive screening needs rise. - The technology’s broader field of view can improve assessment of ocular health compared with conventional imaging.

What happened: - The Business Research Company published its Wide-Field Optical Coherence Tomography (OCT) Imaging Market Report 2026 on July 23, 2026. - The report says the market will grow from $1.14 billion in 2025 to $1.24 billion in 2026, a 9.4% annual growth rate. - The report projects the market will reach $1.8 billion by 2030, growing at a 9.7% annual rate. - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth during the forecast period.

The details: - Wide-field OCT imaging produces high-resolution, cross-sectional and expansive images of biological tissue, especially the retina and surrounding ocular structures. - The technology uses light waves to capture detailed internal images. - The report links historical growth to early OCT development, higher rates of retinal disease and glaucoma, wider use of digital ophthalmic imaging, expansion of hospital diagnostic infrastructure, and advances in laser and light-based imaging. - Forward growth is tied to an aging population, more vision disorders, demand for early detection, preventive ophthalmology, AI-powered diagnostic imaging, telemedicine, remote eye care and healthcare digitization. - Diabetic retinopathy is a major demand driver because the condition can lead to vision loss or blindness if untreated. - Wide-field OCT supports diagnosis and management by showing detailed, wide-area retinal scans that can reveal early vascular changes and track disease progression. - In February 2026, the Australian Institute of Health and Welfare reported that about 919 First Nations people were screened for diabetic retinopathy using retinal cameras in 2023–24, up from about 802 in 2022–23. - The report also says Asia-Pacific growth will be supported by healthcare investment, more vision-related disorders and expanded teleophthalmology services.

Between the lines: - The report suggests wide-field OCT is moving from a specialized imaging option toward a broader clinical workflow tool. - AI, telemedicine and preventive care are not just supporting trends. They are changing how eye disease is screened and managed. - The regional split points to a mature adoption base in North America and a faster growth runway in emerging healthcare markets.

What's next: - Adoption should keep rising as providers look for earlier diagnosis and better long-term monitoring of retinal disease. - Market growth is likely to track continued investment in digital ophthalmology, remote care and AI-enabled imaging systems. - The report is available as a free sample and the full report is also available.